Volume 72August 2011Number 8

1095 Pretest

CME Activity

1106 Posttest


1096 The Prevalence and Comorbidity of Social Anxiety Disorder Among United States Latinos: A Retrospective Analysis of Data From 2 National Surveys

For Clinical Use
  • Although Latinos with social anxiety disorder (SAD) may have a later onset of the disorder than non-Latino whites, they may present with more impairment associated with the disorder across domains of functioning that include work, home, and social relationships.
  • To better evaluate comorbidity among Latinos with SAD, consider a thorough assessment of other anxiety disorders, since those who arrive in the United States as adults may present with unique profiles that include a high risk of agoraphobia.
  • Being fluent in English does not reduce the likelihood of having SAD among Latinos. In fact, those who grew up speaking both English and Spanish were at higher risk than those who grew up speaking primarily Spanish. Screening for SAD should be considered regardless of nativity.


Original Research

1027 Clinical and Cognitive Correlates of Suicide Attempts in Bipolar Disorder: Is Suicide Predictable?

Clinical Points
  • The study’s inability to find reliable neuropsychological predictors confirms the difficulty faced by clinicians in identifying which patients are at greatest risk for suicide attempt.
  • Despite the failure to find reliable predictors of suicidal behavior, thorough clinical assessment of suicide risk by health care professionals continues to be essential.


1034 The Impact of Changing Diagnostic Criteria in Posttraumatic Stress Disorder in a Canadian Epidemiologic Sample

Clinical Points
  • Since its inclusion in DSM-III, PTSD has undergone a number of changes in its diagnostic criteria, which have had a significant impact upon prevalence rates.
  • Changes in PTSD diagnostic Criteria A to E do not appear to have as much influence on the rates of PTSD as does the addition of the Criterion F: clinically significant distress or impairment.
  • This change has raised the diagnostic threshold for PTSD as demonstrated by lower prevalence rates.
  • Moving toward DSM-5, the key issue appears to be how clinically significant distress and functional impairment should be defined.


1042 “Extended” Antipsychotic Dosing in the Maintenance Treatment of Schizophrenia: A Double-Blind, Placebo-Controlled Trial

1049 Childhood Trauma and Depressive Symptoms in Type 1 Diabetes

1054 The Efficacy of Omega-3 Supplementation for Major Depression: A Randomized Controlled Trial

1072 PTSD Comorbidity and Suicidal Ideation Associated With PTSD Within the Ohio Army National Guard

Clinical Points
  • When depression or alcohol dependence accompanies PTSD, view this clinical presentation as being accompanied by high risk for suicidality.
  • Always look for co-occurring depression and alcohol dependence in PTSD.
  • These 2 co-occurring illnesses increase the risk of suicidality more than 7-fold.


1079 Risperidone Long-Acting Therapy Prescribing Patterns and Their Impact on Early Discontinuation of Treatment in a Large Medicaid Population

1086 Efficacy and Safety of Duloxetine 60 mg and 120 mg Daily in Patients Hospitalized for Severe Depression: A Double-Blind Randomized Trial

1124 Corticotropin-Releasing Factor, Interleukin-6, Brain-Derived Neurotrophic Factor, Insulin-Like Growth Factor-1, and Substance P in the Cerebrospinal Fluid of Civilians With Posttraumatic Stress Disorder Before and After Treatment With Paroxetine

Review Articles

1063 Number Needed to Treat to Harm for Discontinuation Due to Adverse Events in the Treatment of Bipolar Depression, Major Depressive Disorder, and Generalized Anxiety Disorder With Atypical Antipsychotics

1108 Relationship Between Daily Dose, Plasma Concentrations, Dopamine Receptor Occupancy, and Clinical Response to Quetiapine: A Review

Early Career Psychiatrists

1129 Acupuncture for the Treatment of Major Depressive Disorder: A Randomized Controlled Trial

1136 Measurement-Based Care in Psychiatric Practice: A Policy Framework for Implementation

1144 Antidepressants for Major Depressive Disorder and Dysthymic Disorder in Patients With Comorbid Alcohol Use Disorders: A Meta-Analysis of Placebo-Controlled Randomized Trials [Review]

Clinical Points
  • Depression and alcohol use disorders often co-occur and may present diagnostic and management challenges.
  • Current evidence supports the efficacy of antidepressants in treating depression in patients with comorbid alcohol abuse and/or dependence.
  • Clinicians should consider the use of antidepressants as first-line therapy for targeting depressive symptoms in patients with unipolar depression and concurrent alcohol use.


ASCP Corner

1152 Assessing the Adequacy of Past Antidepressant Trials: A Clinician’s Guide to the Antidepressant Treatment Response Questionnaire

Letters to the Editor

1155 Treatment Outcome for Bereavement-Excluded Depression: Results of the Study by Corruble et al Are Not What They Seem

1156 Searching For Serendipity

1157 Corrections

Book Reviews

1158 Long-Term Psychodynamic Psychotherapy: A Basic Text, 2nd ed

1158 Depression and Heart Disease

1159 Introductory Textbook of Psychiatry, 5th ed

1159 Depression and Diabetes

CME Activities

e25 Evidence for the Use of l-Methylfolate Combined With Antidepressants in MDD

e26 Safety and Tolerability of Antipsychotic Treatment in Young Patients With Schizophrenia

e27 Selecting Appropriate Treatment for Patients Who Are Nonresponsive to Initial Therapy

information for authors

see www.psychiatrist.com/author.htm